High Burden, Great Opportunity: Preventing Heart Attacks and Strokes
Date:Tuesday, February 23, 2016
Janet S. Wright, MD, FACC
U.S. Department of Health and Human Services
In the shadows of exotic viruses that spark public health emergency responses, are the lingering health effects from cardiovascular disease—the leading cause of death in the United States. Cardiovascular disease, including heart disease and stroke, continues to represent the primary cause of life years lost for one in every three adults. To reduce the burden of heart attack and stroke in the U.S., the Department of Health and Human Services launched Million Hearts®. This initiative aligns policies, programs, and resources to help clinicians improve cardiovascular health for all. During this COCA Call, clinicians will learn about the components of Million Hearts® and the strategies to help find and address the needs of those at greatest risk for cardiovascular disease.
- Describe the key components of Million Hearts® and the targets that must be met to prevent 1 million heart attacks and strokes
- Discuss the accomplishments of Million Hearts®
- State how evidence-based strategies can help identify and address the needs of those at greatest risk for heart attack and stroke
- Discuss the use of standardized treatment approaches to improve outcomes for patients at risk for heart attack and stroke
Million Hearts® Tools and Protocols:
- Hypertension Treatment Protocols
- Finding those with Undiagnosed Hypertension
- Hypertension Control Change Package
- Hypertension Action Steps for Clinicians
- Hypertension Action Steps for Employers
- Self-Measured Blood Pressure Monitoring: Action Steps for Clinicians
- Self-Measured Blood Pressure Monitoring: Action Steps for Public Health
Million Hearts® Partners and Progress:
Million Hearts® Learn and Prevent:
- John’s Story: How I came back from a heart attack
- “It Takes a Team” video
- Spanish language website
- 100 Congregations for Million Hearts®
- Million Hearts® Healthy Eating & Lifestyle Resource Center
- Audio conference call on 2/23/16: 2:00 – 3:00 PM
- Web-on-demand training after 3:00 PM on 2/23/16
- Materials: PowerPoint slide set
“WC2286” for attendees who participate in the live call (must be completed by March 24, 2016)
“WD2286” for attendees who participate in the online presentation (must be completed by March 24, 2018)
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:firstname.lastname@example.org
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.
CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU’s for this program.
CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-076-L04-P and enduring 0387-0000-16-076-H04-P course category.
Course Category: This activity has been designated as knowledge-based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at email@example.com if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.
There is no cost for this program.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC does not accept commercial support.
- Page last reviewed: January 25, 2016 (archived document)
- Content source:
- Maintained By: